A novel action of human apurinic/apyrimidinic endonuclease: excision of L-configuration deoxyribonucleoside analogs from the 3' termini of DNA - PubMed (original) (raw)
. 2000 Oct 6;275(40):31009-15.
doi: 10.1074/jbc.M004082200.
Affiliations
- PMID: 10906132
- DOI: 10.1074/jbc.M004082200
Free article
A novel action of human apurinic/apyrimidinic endonuclease: excision of L-configuration deoxyribonucleoside analogs from the 3' termini of DNA
K M Chou et al. J Biol Chem. 2000.
Free article
Abstract
beta-l-Dioxolane-cytidine (l-OddC, BCH-4556, Troxacitabine) is a novel unnatural stereochemical nucleoside analog that is under phase II clinical study for cancer treatment. This nucleoside analog could be phosphorylated and subsequently incorporated into the 3' terminus of DNA. The cytotoxicity of l-OddC was correlated with the amount of l-OddCMP in DNA, which depends on the incorporation by DNA polymerases and the removal by exonucleases. Here we reported the purification and identification of the major enzyme that could preferentially remove l-OddCMP compared with dCMP from the 3' termini of DNA in human cells. Surprisingly, this enzyme was found to be apurinic/apyrimidinic endonuclease (APE1) (), a well characterized DNA base excision repair protein. APE1 preferred to remove l- over d-configuration nucleosides from 3' termini of DNA. The efficiency of removal of these deoxycytidine analogs were as follows: l-OddC > beta-l-2',3'-dideoxy-2', 3'-didehydro-5-fluorocytidine > beta-l-2',3'-dideoxycytidine > beta-l-2',3'-dideoxy-3'-thiocytidine > beta-d-2',3'-dideoxycytidine > beta-d-2',2'-difluorodeoxycytidine > beta-d-2'-deoxycytidine >/= beta-d-arabinofuranosylcytosine. This report is the first demonstration that an exonuclease can preferentially excise l-configuration nucleoside analogs. This discovery suggests that APE1 could be critical for the activity of l-OddC or other l-nucleoside analogs and may play additional important roles in cells that were not previously known.
Similar articles
- The exonuclease activity of human apurinic/apyrimidinic endonuclease (APE1). Biochemical properties and inhibition by the natural dinucleotide Gp4G.
Chou KM, Cheng YC. Chou KM, et al. J Biol Chem. 2003 May 16;278(20):18289-96. doi: 10.1074/jbc.M212143200. Epub 2003 Mar 6. J Biol Chem. 2003. PMID: 12624104 - Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
Grove KL, Guo X, Liu SH, Gao Z, Chu CK, Cheng YC. Grove KL, et al. Cancer Res. 1995 Jul 15;55(14):3008-11. Cancer Res. 1995. PMID: 7606719 - New nucleoside analogs in the treatment of solid tumors.
Szafraniec SI, Stachnik KJ, Skierski JS. Szafraniec SI, et al. Acta Pol Pharm. 2004 Jul-Aug;61(4):297-305. Acta Pol Pharm. 2004. PMID: 15575597 Review. - Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
Anderson KS. Anderson KS. Biochim Biophys Acta. 2002 Jul 18;1587(2-3):296-9. doi: 10.1016/s0925-4439(02)00092-3. Biochim Biophys Acta. 2002. PMID: 12084471 Review.
Cited by
- Mechanisms of Coronavirus Genome Stability As Potential Targets for Antiviral Drugs.
Yuyukina SK, Zharkov DO. Yuyukina SK, et al. Her Russ Acad Sci. 2022;92(4):470-478. doi: 10.1134/S1019331622040256. Epub 2022 Sep 6. Her Russ Acad Sci. 2022. PMID: 36091852 Free PMC article. - Boron-containing nucleosides as tools for boron-neutron capture therapy.
Zharkov DO, Yudkina AV, Riesebeck T, Loshchenova PS, Mostovich EA, Dianov GL. Zharkov DO, et al. Am J Cancer Res. 2021 Oct 15;11(10):4668-4682. eCollection 2021. Am J Cancer Res. 2021. PMID: 34765286 Free PMC article. Review. - Understanding APE1 cellular functions by the structural preference of exonuclease activities.
Liu TC, Guo KW, Chu JW, Hsiao YY. Liu TC, et al. Comput Struct Biotechnol J. 2021 Jun 24;19:3682-3691. doi: 10.1016/j.csbj.2021.06.036. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34285771 Free PMC article. Review. - APE1 distinguishes DNA substrates in exonucleolytic cleavage by induced space-filling.
Liu TC, Lin CT, Chang KC, Guo KW, Wang S, Chu JW, Hsiao YY. Liu TC, et al. Nat Commun. 2021 Jan 27;12(1):601. doi: 10.1038/s41467-020-20853-2. Nat Commun. 2021. PMID: 33504804 Free PMC article. - Mre11 exonuclease activity removes the chain-terminating nucleoside analog gemcitabine from the nascent strand during DNA replication.
Boeckemeier L, Kraehenbuehl R, Keszthelyi A, Gasasira MU, Vernon EG, Beardmore R, Vågbø CB, Chaplin D, Gollins S, Krokan HE, Lambert SAE, Paizs B, Hartsuiker E. Boeckemeier L, et al. Sci Adv. 2020 May 29;6(22):eaaz4126. doi: 10.1126/sciadv.aaz4126. eCollection 2020 May. Sci Adv. 2020. PMID: 32523988 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous